Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 11:50 am Purchase | 2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK | MORGAN STANLEY MS | 2,448,214 6.200% | 2,448,214 (New Position) | Filing History |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 3,034,649 7.696% | 479,850 (+18.78%) | Filing History |
| 2023-02-09 11:32 am Sale | 2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK | The Vanguard Group | 1,602,045 4.060% | -310,137 (-16.22%) | Filing History |
| 2023-02-03 5:16 pm Purchase | 2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group LLC | 4,166,975 9.700% | 1,920,307 (+85.47%) | Filing History |
| 2023-01-25 3:45 pm Sale | 2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK | Cowen Financial Products LLC | 1,248,077 1.890% | -623,452 (-33.31%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group LLC | 2,246,668 6.100% | -439,566 (-16.36%) | Filing History |
| 2022-02-14 08:07 am Purchase | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW INVESTMENTS LP | 3,644,248 9.900% | 100,000 (+2.82%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | The Vanguard Group | 1,912,182 5.200% | 1,912,182 (New Position) | Filing History |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 2,554,799 6.944% | -1,046,176 (-29.05%) | Filing History |
| 2022-01-24 07:44 am Purchase | 2022-01-19 | 13G | Stoke Therapeutics, Inc. STOK | Cowen Financial Products LLC | 1,871,529 5.090% | 1,871,529 (New Position) | Filing History |
| 2021-06-30 4:19 pm Purchase | 2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 14,443,681 39.300% | 14,443,681 (New Position) | Filing History |
| 2021-06-28 8:54 pm Sale | 2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK | ATP Life Science Ventures L.P. | 1,912,256 5.200% | -15,293,789 (-88.89%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group LLC | 2,686,234 7.400% | 2,686,234 (New Position) | Filing History |
| 2021-02-16 3:15 pm Sale | 2021-02-16 | 13G | Stoke Therapeutics, Inc. STOK | Cormorant Asset Management LP | 1,437,807 3.970% | -350,856 (-19.62%) | Filing History |
| 2021-02-16 10:07 am Sale | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | GILDER GAGNON HOWE & CO LLC | 1,470,841 4.060% | -356,360 (-19.50%) | Filing History |
| 2021-02-12 09:40 am Unchanged | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW INVESTMENTS LP | 3,544,248 9.890% | 0 (Unchanged) | Filing History |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 3,600,975 9.937% | 3,600,975 (New Position) | Filing History |
| 2020-11-27 4:58 pm Purchase | 2020-11-20 | 13D | Stoke Therapeutics, Inc. STOK | ATP Life Science Ventures L.P. | 17,206,045 47.500% | 419,332 (+2.50%) | Filing History |